Diabetic neuropathy is one of the most common and serious complications of diabetes mellitus and metabolic syndrome. The current therapy including glucose control and pain management, are not effective for most patients due the life style. Growing evidence suggests that infiltration of inflammation factors and deficiency of local neurotrophic and angiogenic factors contribute significantly to the pathologies of diabetic neuropathy.
Through conventionally available options, there is no definitive cure to reverse diabetic neuropathy. Alternative treatment regime with cell therapy is therefore gaining prominence. Cell therapy for diabetic neuropathy provides a potential promise of tissue regeneration and rejuvenation for the reversal of eye damage.